Without this pill, lots of people would be dead
25 years ago, the FDA approved a pill that would change the way scientists treat cancer … for good. The pill was called Gleevec; it was designed specifically to treat CML, chronic myeloid leukemia, and it was one of the first targeted cancer therapies available. A quarter century after approval, it’s still being…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from Short Wave
See all episodes →
Similar episodes from other shows
More like Short Wave →
Why Cancer Death Rates Have Decreased Over The Last 30 Years
Are we ready to cure cancer?
New Treatment Saves Children With Terminal Brain Cancer
‘The undruggable became druggable’: a gamechanging treatment for the world’s deadliest cancer
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.